A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1

Authors :: Roestenberg, Meta
Walk, J.
Boor, Saskia C. van der
Langenberg, Marijke C.C.
Hoogerwerf, Marie-Astrid
Janse, Jacqueline J.
Teelen, K.A.
Waardenburg, Y.M. van
Vegte-Bolmer, M.G. van de
Gemert, G.J. van
Ven, A.J.A.M. van der
Mast, Q. de
Khan, Shahid M.
Sauerwein, R.W.
Roestenberg, Meta
Walk, J.
Boor, Saskia C. van der
Langenberg, Marijke C.C.
Hoogerwerf, Marie-Astrid
Janse, Jacqueline J.
Teelen, K.A.
Waardenburg, Y.M. van
Vegte-Bolmer, M.G. van de
Gemert, G.J. van
Ven, A.J.A.M. van der
Mast, Q. de
Khan, Shahid M.
Sauerwein, R.W.
Source :: Science Translational Medicine; 1946-6234; 544; 12; eaaz5629; ~Science Translational Medicine~~~~~1946-6234~544~12~~eaaz5629
Publication Year :: 2020
Abstract: Item does not contain fulltext

Database :: OAIster
Journal :: Science Translational Medicine; 1946-6234; 544; 12; eaaz5629; ~Science Translational Medicine~~~~~1946-6234~544~12~~eaaz5629
Publication Type :: Electronic Resource
Accession number :: edsoai.on1247301953
Document Type :: Electronic Resource

Tools